ChipBio
Latest round
- Series A
Last raised
- Jul 2025
Total raised
- Undisclosed
Investors
- 4
About ChipBio
, Ltd. focuses on biomedical technologies, particularly in developing advanced biomaterials and medical devices., Ltd. specializes in the development and manufacturing of advanced biomaterials and implantable medical devices tailored for various medical fields, including medical aesthetics, urology, orthopedics, and oral repair. Their core product offerings include medical-grade collagen, cross-linked yak pericardium, micronized acellular dermal matrix (mADM), small intestinal submucosa (SIS), polycaprolactone (PCL) microspheres, and poly-L-lactic acid (PLLA) microspheres. These products are engineered to address critical healthcare needs by providing solutions for tissue repair, enhancement, and aesthetic applications, leveraging their exceptional biocompatibility., Ltd. generates revenue primarily through direct sales of its biomaterials and medical devices to healthcare providers and institutions. The company engages in business-to-business transactions, establishing partnerships with hospitals and clinics that utilize its products in surgical and aesthetic procedures. Transactions are structured on an order basis, where clients place bulk orders for specific biomaterials or medical devices tailored to their operational needs. The pricing structure for these products aligns with industry standards, reflecting the advanced nature of the technologies and materials used. The company plans to utilize these funds to support the development of new innovative products aimed at expanding their product lineup. Additionally, ChipBio is targeting expansion into new markets, with a focus on increased presence in Southeast Asia by 2026.
Who invested in ChipBio
4 investors across 1 round
See all investors in ChipBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 22, 2025
Amount
Undisclosed
Investors
Questions about ChipBio
Who invested in ChipBio?
ChipBio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ChipBio raised?
ChipBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ChipBio last raise money?
ChipBio's most recent round on record is a Series A, in Jul 2025.
What does ChipBio do?
ChipBio is a biotechnology company.
Where is ChipBio headquartered?
ChipBio is headquartered in Chengdu, China.
Which VCs invest in companies like ChipBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ChipBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ChipBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.